Who Gets Hired
A biotech company that more than doubled its headcount in three years doesn't hire by accident — and MyOme's interview loop, built to screen for both technical depth and collaborative mindset, reveals exactly what it takes to get in. MyOme grew from 26 people in 2023 to 83 by March 2026. Active job postings nearly tripled to 19 open roles; new postings per month climbed from two to seven. That pace signals a shift from early R&D into commercial execution, and the roles being filled reveal exactly where the bottlenecks sit.
MyOme, founded in 2017 and based in San Carlos, California, uses whole-genome sequencing and proprietary bioinformatics to generate clinically actionable risk reports for patients and providers. According to Revelio Labs, among its peers, it ranks sixth by headcount — larger than Inflammatix (76) and CapForce (68), smaller than Maze Therapeutics (143) and Freenome (51), dwarfed by Natera (6,147) and GRAIL (953). But its functional split is unusual: Sales and Marketing leads at just over a third of the workforce, Finance and Operations follows at just over a third, and Engineering sits at just under a third. Finance and Operations is also growing fastest, up 38 percent year over year, Revelio Labs reported, suggesting the infrastructure build-out is outpacing even the commercial push.
The open roles map directly to that structure. On the science side, MyOme is hiring a Wet Lab Staff Scientist in Menlo Park, a Scientist in Computational Biology in Menlo Park, a Senior Scientist in Clinical Biostatistics and Genetic Risk Prediction in Menlo Park with remote flexibility, and a Bioinformatics Scientist/Biostatistician contractor in Menlo Park. Clinical operations needs a Senior Clinical Trial Manager (remote) and Genetic Counseling Assistants in Denver or remote. Commercial operations is adding a Revenue Cycle Specialist in Charlotte, an RCM Analyst and Billing Specialist remote, and a Quality Assurance Specialist in Menlo Park. Engineering is recruiting a Senior Full Stack Engineer in San Francisco. People operations wants a Senior Human Resources Business Partner in Menlo Park with remote option.
Geographically, nearly the entire workforce sits in North America, with a small Eastern Europe presence. Current postings cluster around the Bay Area, Menlo Park and San Francisco, with satellite roles in Charlotte, Denver, and fully remote positions for clinical counseling, billing, and HR. The company's own careers page groups its hiring needs into five domains: Genomics and Bioinformatics, Software Engineering and Data Science, Clinical and Medical Affairs, Regulatory and Compliance, and Operations and Commercial Strategy. That taxonomy matches the live postings almost exactly.
The median salary across the organization is $157,000 in North America, with an average of $159,812, Revelio Labs' data shows — figures broken down by role in the next section. But the hiring pattern itself tells the story: MyOme is staffing a commercial-grade clinical genomics operation, not a research shop.
What It Pays
MyOme's compensation structure reflects a company scaling past early-stage equity-heavy packages into a phase where base salaries compete with established biotech and tech employers in the Bay Area. Zero G Talent's job board (first-party data) shows a salary band running roughly $69,000 to $218,000 across ten salaried postings, with a median of $178,000. That range spans individual-contributor scientist roles through senior engineering and clinical leadership, and it aligns with the functional mix the company advertises.
The board's six most recent postings give a concrete picture of where the market sits today. All figures are annual base salary ranges as posted; equity and benefits are separate.
| Role | Location | Base Salary Range (USD/year) |
|---|---|---|
| Senior Full Stack Engineer | San Francisco, CA | $160,000 – $210,000 |
| Wet Lab Staff Scientist | Menlo Park, CA | $170,000 – $185,000 |
| Senior Clinical Trial Manager | Remote | $145,000 – $185,000 |
| Senior Scientist, Clinical Biostatistics & Genetic Risk Prediction | Menlo Park, CA / Remote | $160,000 – $180,000 |
| Senior Human Resources Business Partner | Menlo Park, CA / Remote | $135,000 – $175,000 |
| Scientist, Computational Biology | Menlo Park, CA | $130,000 – $150,000 |
The engineering ceiling at $210,000 base for a senior full-stack role sits below the $221,100 total compensation (base plus stock and bonus) that Levels.fyi reports for a Software Engineering Manager at the "Common Range Average" level, suggesting MyOme's equity component closes much of the gap. On the clinical side, Salary.com lists a Medical Director at $343,143 — a figure that likely reflects a higher-grade role than the board's current postings capture. The board's median of $178,000 lands squarely in the competitive band for mid-to-senior individual contributors in Menlo Park and San Francisco.
Three of the six roles offer remote flexibility, and their ranges overlap the on-site bands rather than discounting for geography. The Senior Clinical Trial Manager role, fully remote, carries a $145,000–$185,000 range that overlaps the Wet Lab Staff Scientist anchored in Menlo Park. MyOme prices for the role's scope, not the zip code — a practical stance for a company recruiting clinical operations talent nationally.
The company's careers page emphasizes "mission-driven innovators" and "innovate with purpose." Benefits data from Glassdoor is available but not detailed in public sources. The compensation mechanics are conventional — base salary calibrated to market, equity as the retention lever, and clinical-grade benefits that match the regulated environment the team operates in.
For candidates, the takeaway is straightforward: MyOme pays market-rate base salaries for the Bay Area, with equity upside tied to a valuation tracked by PitchBook. That median is the number to benchmark against; roles at the top of the band (senior engineering, staff scientist, clinical leadership) approach $200,000 base before equity. Negotiation room exists, but the posted ranges are narrow (typically $20,000–$50,000 spreads), suggesting the company bands tightly and expects candidates to self-select into the right level. That same discipline shapes the interview process.
How the Hiring Process Works
Public interview data on MyOme is sparse. Glassdoor shows a single anonymous review and zero posted questions as of April 2025. InterviewQuery catalogs topic frequencies from candidate-reported sessions: Data Structures & Algorithms (26), Machine Learning (19), SQL (13), Product Sense & Metrics (10), and Behavioral (8). That distribution weights core computer-science fundamentals heavily, then layers on ML fluency, data-query skill, product judgment, and cultural alignment — roughly in that order.
The company's careers page frames the bar in mission language: "mission-driven innovators," "creative problem-solving and bold thinking," "trust, transparency, and a shared commitment to excellence." Those phrases function as cultural screen criteria. Adam Lavertu, Head of Engineering, said the environment is one where "everyone is passionate and smart, yet humble and willing to listen" and where he feels "a voice in the future direction of the company." Founder Matt Rabinowitz anchors the mission in a personal mantra: "Work on the health challenges faced by the people close to you, and the world will be better for it."
The interview process details are not publicly documented beyond topic areas. Candidates should expect technical assessment aligned with the role families and cultural alignment with the published values. A strong application mirrors the company's published values. Referrals from current team members carry weight; the 83-person headcount (Revelio Labs, March 2026, up 14.2 percent year-over-year) means the social graph is dense enough that a warm intro often bypasses the initial resume screen.
Where the Work Happens
MyOme's physical footprint reflects its dual identity as a clinical laboratory and a computational genomics platform. The company's primary wet-lab operation sits in Menlo Park, California, where it has maintained a CLIA-certified, CAP-accredited clinical laboratory since at least February 2022, according to the National Provider Identifier registry. That certification authorizes the facility to perform high-complexity clinical laboratory testing, the regulatory floor for returning patient-grade whole-genome results.
A second hub appears in Palo Alto, listed on LinkedIn as "MyOme Biotechnology Research." The distinction appears to reflect a division between regulated clinical pipeline and research and development. That split shows up in the job board. The Wet Lab Staff Scientist role is anchored in Menlo Park, while the Scientist, Computational Biology role and the Senior Scientist, Clinical Biostatistics & Genetic Risk Prediction role are both listed for Menlo Park with a remote option. The Senior Full Stack Engineer role is based in San Francisco, roughly 30 miles north, placing the engineering team closer to the Bay Area's software talent pool while the clinical lab stays planted in the Peninsula's biotech corridor.
The computational infrastructure is cloud-native. MyOme's public GitHub repositories (deepnano-blitz for Oxford Nanopore basecalling, CNVnator and TIDDIT for structural-variant calling, bcftools_score_plugin for polygenic scoring, and amazon-ebs-autoscale for elastic storage on EC2) reveal a stack built on AWS. The amazon-ebs-autoscale tool, updated June 2026, automatically provisions EBS volumes when disk utilization spikes during large-scale sequencing analysis.
The careers page describes the model as "built for the settings where care happens" and emphasizes an "end-to-end support model [that] integrates effortlessly into busy clinics." In practice, that means the physical sites are optimized for throughput and chain-of-custody. MyOme buys Illumina and Oxford Nanopore instruments off the shelf.
Remote roles extend the footprint without new leases. The Senior Clinical Trial Manager and the Senior Human Resources Business Partner are both listed as Menlo Park or remote, reflecting a post-2020 norm where clinical operations and people ops can sit anywhere the regulatory paperwork allows. The expansion signal ("We're expanding our Engineering, Commercial, Research, and Clinical Operations teams") suggests the Menlo Park lab will absorb more throughput, the Palo Alto research group will push new polygenic models into the clinical pipeline, and the San Francisco engineering team will keep hardening the cloud platform that ties them together.
Who Thrives
The people who stay and advance at MyOme share a cluster of traits that the company's hiring record and its employees' own words make visible. The career page describes the search for "mission-driven innovators," phrasing that reads like boilerplate until you cross-reference it with the roles actually being filled. That senior scientist role, a Wet Lab Staff Scientist, a Senior Full Stack Engineer, and a Senior Clinical Trial Manager are not generic innovation hires; they are specialists who must translate genomic data into clinical action. The common thread is not a personality type but a working orientation: comfort operating where the science is not yet settled and the regulatory path is still being written.
Blind reviews, sparse as they are, converge on two signals. The team is described as "great to work with" and the product as "rewarding to work on." The field is called "exciting." That language maps directly to the workload: whole-genome sequencing at clinical scale, AI-driven interpretation, and a commercial push that followed an Illumina collaboration deal. People who thrive here treat ambiguity as the default state. The same review that awards Career Growth a 5.0 notes the flip side, "no career ladder so you have to advocate for yourself to get package bumps." Management also scores 5.0, but in a one-review sample that reads less like praise and more like a warning: the structure is thin, and the burden of navigation falls on the individual.
The hiring mix reinforces the profile. Those four areas are all expanding simultaneously. The board's salary band ($69k to $218k with a $178k median across ten salaried roles) reflects that breadth, but it also signals that the company pays for depth. The senior HR business partner at $135k–$175k sits beside a Senior Full Stack Engineer at $160k–$210k; the parity suggests the organization values operational maturity as much as technical firepower.
What disqualifies candidates is the inverse of what the work demands. The mission language on the careers page is not aspirational; it is a filter. The people who last are the ones who would do the work even if the title didn't change for two years, because the genome they're interpreting today changes a patient's care tomorrow.
Working in frontier tech? Zero G Talent tracks the openings: see every open MyOme role, browse frontier tech jobs, the companies hiring, and the people building the field.